i don't have much hope on ASIC to be honest. Perhaps it's time to use the master's philosophy and topup . There is a possibility that someone keen on Evolis alone is not happy with the fact that any profit from that will be used on the Biotech side(loss making entity and unlikely that it would change in the foreseeable future).
